Gisslen M - Search Results

1

Viral co-infection, autoimmunity, and CSF HIV antibody profiles in HIV central nervous system escape.

Hawes IA, Alvarenga BD, Browne W, Wapniarski A, Dandekar R, Bartley CM, Sowa GM, DeRisi JL, Cinque P, Dravid AN, Pleasure SJ, Gisslen M, Price RW, Wilson MR. Hawes IA, et al. Among authors: gisslen m. J Neuroimmunol. 2023 Aug 15;381:578141. doi: 10.1016/j.jneuroim.2023.578141. Epub 2023 Jun 28. J Neuroimmunol. 2023. PMID: 37418948 Free article.

2

The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations.

Cinque P, Nebuloni M, Santovito ML, Price RW, Gisslen M, Hagberg L, Bestetti A, Vago G, Lazzarin A, Blasi F, Sidenius N. Cinque P, et al. Among authors: gisslen m. Ann Neurol. 2004 May;55(5):687-94. doi: 10.1002/ana.20076. Ann Neurol. 2004. PMID: 15122709

3

Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease.

Sidenius N, Nebuloni M, Sala S, Zerbi P, Price RW, Gisslen M, Hagberg L, Vago L, Lazzarin A, Blasi F, Cinque P. Sidenius N, et al. Among authors: gisslen m. J Neuroimmunol. 2004 Dec;157(1-2):133-9. doi: 10.1016/j.jneuroim.2004.08.038. J Neuroimmunol. 2004. PMID: 15579290

4

Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection.

Cinque P, Bestetti A, Marenzi R, Sala S, Gisslen M, Hagberg L, Price RW. Cinque P, et al. Among authors: gisslen m. J Neuroimmunol. 2005 Nov;168(1-2):154-63. doi: 10.1016/j.jneuroim.2005.07.002. Epub 2005 Aug 8. J Neuroimmunol. 2005. PMID: 16091292

5

Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection.

Gisslén M, Rosengren L, Hagberg L, Deeks SG, Price RW. Gisslén M, et al. AIDS Res Ther. 2005 Aug 18;2:6. doi: 10.1186/1742-6405-2-6. AIDS Res Ther. 2005. PMID: 16109178 Free PMC article.

6

Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment.

Mellgren A, Antinori A, Cinque P, Price RW, Eggers C, Hagberg L, Gisslén M. Mellgren A, et al. Among authors: gisslen m. Antivir Ther. 2005;10(6):701-7. Antivir Ther. 2005. PMID: 16218168 Clinical Trial.

7

CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration.

Abdulle S, Mellgren A, Brew BJ, Cinque P, Hagberg L, Price RW, Rosengren L, Gisslén M. Abdulle S, et al. Among authors: gisslen m. J Neurol. 2007 Aug;254(8):1026-32. doi: 10.1007/s00415-006-0481-8. Epub 2007 Apr 10. J Neurol. 2007. PMID: 17420923

8

Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex.

Gisslen M, Hagberg L, Brew BJ, Cinque P, Price RW, Rosengren L. Gisslen M, et al. J Infect Dis. 2007 Jun 15;195(12):1774-8. doi: 10.1086/518043. Epub 2007 May 2. J Infect Dis. 2007. PMID: 17492593

9

Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy.

Yilmaz A, Price RW, Spudich S, Fuchs D, Hagberg L, Gisslén M. Yilmaz A, et al. Among authors: gisslen m. J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):168-73. doi: 10.1097/QAI.0b013e31815ace97. J Acquir Immune Defic Syndr. 2008. PMID: 17971711 Free PMC article.

10

Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkers.

Gisslen M, Hagberg L, Rosengren L, Brew BJ, Cinque P, Spudich S, Price RW. Gisslen M, et al. J Neuroimmune Pharmacol. 2007 Mar;2(1):112-9. doi: 10.1007/s11481-006-9035-1. Epub 2006 Sep 12. J Neuroimmune Pharmacol. 2007. PMID: 18040834 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

310 results

Search Page

Filters